This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Academia Sinica. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Innovations of Yu-Han Liu in Therapeutic Nanoparticles
Introduction
Yu-Han Liu is a prominent inventor based in Taipei, Taiwan. She has made significant contributions to the field of therapeutic nanoparticles, particularly in the development of innovative solutions for treating bacterial infections. Her work is characterized by a strong focus on the intersection of nanotechnology and medicine.
Latest Patents
Yu-Han Liu holds a patent for "Therapeutic nanoparticles by coacervate complexation and their use for treating bacteria." This patent describes a therapeutic nanoparticle that contains a cationic polypeptide and a polyanionic molecule. The cationic polypeptide exhibits antibacterial activity and forms electrostatic interactions with the polyanionic molecule. The therapeutic nanoparticle has a diameter of less than 50 micrometers. Additionally, the patent discloses a pharmaceutical composition, a treatment method, and a preparation method related to the therapeutic nanoparticle.
Career Highlights
Yu-Han Liu is affiliated with Academia Sinica, a prestigious research institution in Taiwan. Her work at Academia Sinica has allowed her to explore advanced research in nanotechnology and its applications in medicine. She has demonstrated a commitment to innovation and excellence in her field.
Collaborations
Yu-Han Liu has collaborated with notable colleagues, including Che-Ming Jack Hu and Te-Li Chen. These collaborations have further enriched her research and contributed to the advancement of therapeutic nanoparticle technology.
Conclusion
Yu-Han Liu's innovative work in therapeutic nanoparticles showcases her dedication to addressing critical medical challenges. Her contributions are paving the way for new treatment options in the fight against bacterial infections.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
